Programme
The “Belgian Biotech and Health Valley” has a tradition of scientific and industrial excellence and has built a strong ecosystem, bringing together leading players at every stage of the innovation value chain. As a true vaccine powerhouse, Belgium can count on the expertise of many specialized companies, from R&D to bioproduction and logistics.
Discover the global impact of Belgian excellence in Next-Gen Vaccines with a panel of national & international experts during bio.be/essenscia’s annual event on 7 October 2024 in the splendid setting of the Egmont Palace in Brussels!
Programme
13:30 : Welcome & registration
14:00 – 16:00 : Plenary Session
- Welcoming
Tineke Van hooland, Deputy Secretary General bio.be/essenscia - Opening keynote speech
Jeroen Cooreman, Director-General for Bilateral Affairs, Ministry of Foreign Affairs Belgium - Panel debates
Moderated by Frédéric Druck, Secretary General bio.be/essenscia - R&D/Innovation
Emmanuel Amory, Managing Director, GSK Belgium
Hanne Callewaert, Chief Executive Officer & Co-founder, AstriVax
Arnaud Marchant, Director, European Plotkin Institute for Vaccinology
Pierre Van Damme, Professor Vaccinology & Infectious Diseases, UAntwerpen
Production/Logistic
José Castillo, Chief Executive Officer, Quantoom Biosciences
Ranna Eardley-Patel, Biologics and Vaccines Manufacturing Expert, CEPI
Luc Van Steenwinkel, Managing Director, Pfizer Manufacturing Belgium
Linde Van Vlasselaer, Global Industry Lead Healthcare, H.Essers - Conclusion
Geoffrey Pot, Chairman bio.be/essenscia
16:00 – 17:30 : Networking reception
We look forward to seeing you on October 7 at Egmont Palace in Brussels.
